Catheters Market Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis

Coverage: Catheters Market covers analysis By Type (Cardiovascular Catheters, Intravenous Catheters, Urology Catheters, Specialty Catheters, and Neurovascular Catheters), End Users (Hospitals, Ambulatory Surgical Centers, Dialysis Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)

Publication Month : Apr 2024

  • Report Code : TIPHE100001327
  • Category : Medical Device
  • Status : Upcoming
  • No. of Pages : 150
Inquire Before Buy

PRICING

$5190

$4671

[Research Report] The global catheters market size is projected to surge from US$ 22.56 billion in 2022 to US$ 46.42 billion by 2030; the market is estimated to grow at a CAGR of 8.5% during 2022–2030.

Analyst Perspective:

Due to the increasing incidence of cardiovascular diseases, kidney diseases, urinary tract procedures, and increasing demand for minimally invasive surgeries, the demand for catheters is expected to remain high in the coming years. The high prevalence rate of chronic diseases leading to hospitalization has fueled the growth of the market. Furthermore, an increase in mid-sized catheter manufacturers looking to capture a higher market share, as well as an increase in funding from various government agencies for research and development activities, is expected to promote market growth during the forecast period. Furthermore, the growing geriatric population is also expected to be a major factor driving the demand for catheters in the near future. Additionally, increasing initiatives by key market players to launch their products is expected to further propel the growth of the market. For example, in July 2021, Medtronic plc launched its drug-eluting balloon catheter (DCB) Prevail under the CE mark (Conformité Européenne) in Europe. The newest coronary DCB on the market, the Prevail DCB, is used in percutaneous coronary intervention (PCI) to treat narrowed or blocked coronary arteries in patients with coronary artery disease (CAD). However, complications related to catheters and the presence of substitutes may hinder the growth of the market.

Market Overview:

Catheters are medical devices that can be injected into the body to treat illness or perform a surgical procedure. By changing and modifying the way catheters are manufactured, it is possible to adapt catheters for cardiovascular, urologic, gastrointestinal, neurovascular, and ophthalmic applications. Catheters are made from different materials and, therefore, can be left in place for many weeks. Various polymers are used in the manufacture of catheters, including silicone rubber, nylon, polyurethane, polyethylene terephthalate (PET), latex, and thermoplastic elastomers. Silicone is one of the most popular implantable options because it is inert and will not react to body fluids and a variety of medical fluids that it may come into contact with. Catheterization is a basic, common procedure performed along with various other medical procedures such as angioplasty, cardiac electrophysiology, and neurosurgery that use catheters. There are different types of catheters on the market, including cardiovascular catheters, neurovascular catheters, urinary catheters, intravenous catheters, and specialty catheters. In addition, among the catheters mentioned above, the cardiovascular catheter is the most commonly used.

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Catheters Market: Strategic Insights

catheters-market
Analyst Image

Akshay

Have a question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Analyst Image  Speak to Analyst

Market Driver:

Rising Number Of Cases of Chronic Ailments Drive Global Catheters Market

According to the Brain Aneurysm Foundation, as of March 2021, approximately 500,000 deaths are caused by brain aneurysms worldwide each year, and half of these individuals are 50 years old or younger. The annual rupture rate is about 8-10 people per 100,000 or about 30,000 people in the United States. Therefore, with the increasing prevalence of neurovascular diseases, the demand for neurovascular catheter devices is also expected to increase. Cardiovascular, urological, and neurological diseases have been among the leading causes of morbidity and mortality rates worldwide over the past three decades. People who perform sedentary jobs are more likely to develop chronic conditions such as diabetes, cardiovascular diseases (CVDs), urological diseases (including end-stage renal disease or end-stage renal disease), and other diseases. According to the American Heart Association, around 19 million deaths worldwide were attributed to cardiovascular disease in 2020. Furthermore, it was estimated that 244 million people were living with ischemic heart disease (IHD) worldwide in 2020. The rise in cardiovascular disease will increase the number of hospitalizations and medical procedures, which in turn is expected to drive the adoption of catheters.

One of the most serious impacts of this trend is kidney failure, which is most commonly caused by chronic diseases such as high blood pressure and diabetes. Urinary tract infections, lupus, polycystic kidney disease, glomerulonephritis, and other kidney abnormalities are the most common causes of kidney problems. Poor lifestyle choices, including inadequate physical exercise, excessive alcohol consumption, smoking, obesity, and inconsistent dietary habits, are some of the causes of the increase in cardiovascular and neurovascular diseases. As these diseases spread, more and more people will need to use catheters, increasing demand over the forecast period. Hence, the rising number of cases of chronic ailments is driving the global catheters market growth.

  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities

Segmental Analysis:

Based on type, the catheters market is segmented into cardiovascular catheters, intravenous catheters, urology catheters, specialty catheters, and neurovascular catheters. The cardiovascular catheters segment held a larger market share in 2022. However, the market for urology catheters segment is anticipated to register a higher CAGR during 2022–2030 owing to the use of urological catheters increases due to the increasing prevalence of end-stage renal disease, kidney problems, and urinary tract infections.

The significant market share of cardiovascular catheters is due to several advantages that the catheters offer for chronic diseases. The catheters provide minimally invasive access to the vascular systems, reducing the need for open surgical procedures. The cardiovascular catheter segment is divided into electrophysiology catheters, percutaneous transluminal coronary angioplasty balloon catheters (PTCA), intravascular ultrasound (IVUS catheters), percutaneous transluminal angioplasty catheters (PTA), and others include guide catheters, angiography catheters, and pulmonary artery catheters. Cardiovascular catheters help with diagnostic purposes, such as angiography, in which a contrast agent is injected through the catheter to visualize blood vessels and assess blood flow. This allows healthcare professionals to diagnose and treat a wide range of cardiovascular diseases, improving patient outcomes and reducing the need for more invasive surgical procedures.

In addition, the urology catheter segment is divided into dialysis catheter and urinary catheter. The dialysis catheter segment is divided into hemodialysis catheter and peritoneal catheter. The urinary catheter segment is divided into a Foley catheter, an intermittent catheter, and an external catheter. The urinary catheters were used for surgical purposes, and the demand was partly affected by the temporary postponement of various elective surgeries. In addition, according to the study titled "Prevalence and associated factors of urinary incontinence among women living in China: a literature review," published in October 2020, approximately 43-349 million Chinese women were suffering from urinary incontinence (UI). The rising prevalence of urinary incontinence and the increasing number of surgical procedures are the major factors driving the demand for urology catheters, thereby fueling the growth of the segment.

  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities

Regional Analysis:

The most developed market for catheters is in North America. Chronic diseases are becoming more common, government policies are supporting them, awareness is developing, competent, qualified doctors are available, and there are well-established healthcare facilities, all contributing to regional growth. In addition, increasing private research funding for innovative device R&D activities has a positive impact on the market expansion of this region. Other factors driving market expansion include a well-established healthcare infrastructure and an increase in lifestyle-related chronic diseases. The market rise in North America is partly due to an increasing number of patients undergoing surgical procedures and greater awareness of minimally invasive catheterization techniques.

Europe is the second largest region. Europe's robust healthcare system has transitioned from inpatient to outpatient care due to the increase in companies offering catheters. The market growth is expected to be largely influenced by the growing demand of the senior population for better healthcare facilities and the increasing interest of patients in less invasive procedures. The rapidly growing older population in this region is predicted to suffer from chronic diseases such as incontinence, peripheral vascular disease, and heart problems, and Europe's population is highly reliant on publicly supported health services.

The fastest-growing region is Asia Pacific. This is because kidney and cardiovascular problems are more common, medical facilities are better, and insurance policies are available. The key growth engines in Asia Pacific are China and India, while Japan's population is aging rapidly. Furthermore, China and India are projected to grow the fastest during the forecast period. However, a shortage of nephrologists and cardiac surgeons could hinder the industry's growth.

Key Player Analysis:

The catheters market analysis consists of players such as B. Braun Melsungen AG, Teleflex Incorporated, Cook Group, PACIFIC HOSPITAL SUPPLY CO. LTD, Johnson & Johnson Services, Inc., BD, Boston Scientific Corporation, Medtronic, Cardinal Health, and C. R. Bard, Inc.

Recent Developments: 

Companies in the catheter market highly adopt inorganic and organic strategies such as mergers and acquisitions. A few recent key market developments are listed below:

  • In June 2023, Inari Medical launched two new purpose-designed thrombectomy catheters to address the needs of venous stent thrombosis and venous thromboembolism (VTE), namely the Triever16 Curve catheter and the RevCore thrombectomy catheter.
  • In February 2023, Teleflex announced that its Triumph catheter, which features a novel design that enables precise wire delivery and clear visualization, received 510(k) clearance from the US FDA. Additionally, the company said its GuideLiner coastal catheter saw its first clinical use at the UW Medicine Heart Institute in Seattle, Washington.
  • In December 2022, Boston Scientific announced a strategic investment to acquire a majority stake in Chinese medical technology company Acotec Scientific Holdings Limited. The company is known in China for, among other things, its drug-coated balloons (DCBs), as well as thrombus aspiration catheters and RF ablation technologies. Boston Scientific aims to strengthen its position in the region with this deal.
  • In March 2022, Shockwave Medical launched its Shockwave M5+ peripheral intravascular lithotripsy catheter after receiving both CE Mark and US Food and Drug Administration (FDA) approval.
  • In March 2022, Cerus Endoscopic received US Food and Drug Administration (FDA) approval for its 027 microcatheters, available in two lengths, expanding its product portfolio, which includes the already FDA-approved 021 microcatheter platform heard.
  • In February 2022, Teleflex announced that the company's specialty catheters and coronary guidewires received approval from the US FDA for an expanded indication for use in CTO PCI (percutaneous coronary interventions with chronic total occlusion). Devices receiving this clearance included the TrapLiner Catheter, Teleflex GuideLiner V3 Catheter, Specter Guidewire, Turnpike Catheters, Bandit Guidewire, Raider Guidewire, R350 Guidewire, and Warrior guide wire.
  • In February 2022, Cerenovus, part of the Johnson & Johnson Medical Devices Companies, launched its Emboguard, a next-generation balloon guiding catheter for use in endovascular procedures, including those in patients with acute ischemic stroke.
  • In January 2022, ICU Medical acquired Smiths Medical from Smiths Group plc. Smiths Medical specializes in providing syringe and outpatient infusion equipment, vascular access, and vital care solutions.
  • In January 2022, Convatec announced the expansion of the Cure Ultra-portable and intermittent catheter range to include an option for women - the Cure Ultra Plus. The device with a length of 8 inches is designed to solve the problem of shortness of the traditional female catheter with a length of 6 inches, which becomes inconvenient to use.
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

The List of Companies

1. B. Braun Melsungen AG
2. Teleflex Incorporated.
3. Cook Group
4. PACIFIC HOSPITAL SUPPLY CO. LTD.
5. Johnson & Johnson Services, Inc.
6. BD
7. Boston Scientific Corporation
8. Medtronic
9. Cardinal Health.
10. C. R. Bard, Inc.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • 3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • 3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • 3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • 3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Catheters Market